Hutner Capital Management Inc Novartis Ag Transaction History

Hutner Capital Management Inc

  • $207 Million
  • Q4 2024

A detailed history of Hutner Capital Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Hutner Capital Management Inc holds 5,894 shares of NVS stock, worth $659,420. This represents 0.28% of its overall portfolio holdings.

Number of Shares
5,894
Previous 2,570 129.34%
Holding current value
$659,420
Previous $295,000 94.24%
% of portfolio
0.28%
Previous 0.15%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$96.78 - $117.18 $321,696 - $389,506
3,324 Added 129.34%
5,894 $573,000
Q3 2024

Nov 13, 2024
BUY
$106.13 - $120.89 $68,666 - $78,215
647 Added 33.65%
2,570 $295,000
Q2 2024

Aug 13, 2024
BUY
$92.57 - $107.37 $178,012 - $206,472
1,923 New
1,923 $204,000
Q4 2023

Feb 14, 2024
SELL
$92.27 - $101.54 $16,608 - $18,277
-180 Reduced 8.11%
2,040 $205,000
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $5,683 - $6,307
-60 Reduced 2.63%
2,220 $226,000
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $9,443 - $10,951
-118 Reduced 4.92%
2,280 $209,000
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $27,802 - $34,047
-368 Reduced 13.3%
2,398 $217,000
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $140,117 - $163,874
-1,878 Reduced 40.44%
2,766 $210,000
Q2 2022

Aug 11, 2022
SELL
$80.52 - $93.75 $122,068 - $142,125
-1,516 Reduced 24.61%
4,644 $393,000
Q1 2022

May 13, 2022
SELL
$80.11 - $90.62 $30,762 - $34,798
-384 Reduced 5.87%
6,160 $541,000
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $43,516 - $48,118
-546 Reduced 7.7%
6,544 $572,000
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $346,992 - $403,679
-4,243 Reduced 37.44%
7,090 $580,000
Q2 2021

Aug 13, 2021
SELL
$85.24 - $94.15 $405,827 - $448,248
-4,761 Reduced 29.58%
11,333 $1.03 Million
Q1 2021

May 18, 2021
SELL
$83.5 - $98.47 $30,227 - $35,646
-362 Reduced 2.2%
16,094 $1.38 Million
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $13,974 - $16,902
-179 Reduced 1.08%
16,456 $1.55 Million
Q3 2020

Nov 13, 2020
BUY
$82.14 - $91.0 $167,565 - $185,640
2,040 Added 13.98%
16,635 $1.45 Million
Q2 2020

Aug 14, 2020
BUY
$80.93 - $91.1 $158,299 - $178,191
1,956 Added 15.48%
14,595 $1.28 Million
Q1 2020

May 13, 2020
SELL
$70.67 - $99.01 $1.09 Million - $1.52 Million
-15,380 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$85.54 - $94.26 $184,082 - $202,847
2,152 Added 16.27%
15,380 $1.34 Million
Q2 2019

Aug 07, 2019
BUY
$75.4 - $92.8 $190,988 - $235,062
2,533 Added 23.68%
13,228 $1.21 Million
Q1 2019

May 10, 2019
BUY
$75.32 - $86.15 $276,424 - $316,170
3,670 Added 52.24%
10,695 $1.03 Million
Q4 2018

Feb 12, 2019
BUY
$73.66 - $82.02 $517,461 - $576,190
7,025 New
7,025 $603,000

Others Institutions Holding NVS

# of Institutions
1,477
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $241B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Hutner Capital Management Inc Portfolio

Follow Hutner Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hutner Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hutner Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email